When Tony Wood became GSK’s top scientist in mid-2022, the British pharma was waging battle.
GSK was fighting Zantac-related litigation in court while struggling to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.